159 related articles for article (PubMed ID: 33633315)
1. Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care.
Agarwal N; Citla Sridhar D; Malay S; Patil N; Shekar A; Ahuja S; Dalal J
Sci Rep; 2021 Feb; 11(1):4654. PubMed ID: 33633315
[TBL] [Abstract][Full Text] [Related]
2. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
Filipovich AH; Stone JV; Tomany SC; Ireland M; Kollman C; Pelz CJ; Casper JT; Cowan MJ; Edwards JR; Fasth A; Gale RP; Junker A; Kamani NR; Loechelt BJ; Pietryga DW; Ringdén O; Vowels M; Hegland J; Williams AV; Klein JP; Sobocinski KA; Rowlings PA; Horowitz MM
Blood; 2001 Mar; 97(6):1598-603. PubMed ID: 11238097
[TBL] [Abstract][Full Text] [Related]
3. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.
Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V;
Haematologica; 2017 Jun; 102(6):1112-1119. PubMed ID: 28255019
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging treatment options for Wiskott-Aldrich syndrome.
Worth AJ; Thrasher AJ
Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
[TBL] [Abstract][Full Text] [Related]
5. Bleeding and splenectomy in Wiskott-Aldrich syndrome: A single-centre experience.
Rivers E; Worth A; Thrasher AJ; Burns SO
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1042-1044.e1. PubMed ID: 30048768
[No Abstract] [Full Text] [Related]
6. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
7. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Wiskott-Aldrich Syndrome With Myeloablative Conditioning.
Sharma A; Rastogi N; Kapoor R; Chatterjee G; Yadav SP
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e230-e233. PubMed ID: 32459721
[TBL] [Abstract][Full Text] [Related]
8. Risk factor analysis of bloodstream infection in pediatric patients after hematopoietic stem cell transplantation.
Sarashina T; Yoshida M; Iguchi A; Okubo H; Toriumi N; Suzuki D; Sano H; Kobayashi R
J Pediatr Hematol Oncol; 2013 Jan; 35(1):76-80. PubMed ID: 22995926
[TBL] [Abstract][Full Text] [Related]
9. [Wiskott-Aldrich syndrome: the possibilities of diagnosis and treatment].
Krisiukeniene A; Sitkauskiene B; Sakalauskas R
Medicina (Kaunas); 2003; 39(3):211-6. PubMed ID: 12695631
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.
Ozsahin H; Cavazzana-Calvo M; Notarangelo LD; Schulz A; Thrasher AJ; Mazzolari E; Slatter MA; Le Deist F; Blanche S; Veys P; Fasth A; Bredius R; Sedlacek P; Wulffraat N; Ortega J; Heilmann C; O'Meara A; Wachowiak J; Kalwak K; Matthes-Martin S; Gungor T; Ikinciogullari A; Landais P; Cant AJ; Friedrich W; Fischer A
Blood; 2008 Jan; 111(1):439-45. PubMed ID: 17901250
[TBL] [Abstract][Full Text] [Related]
11. How I manage patients with Wiskott Aldrich syndrome.
Rivers E; Worth A; Thrasher AJ; Burns SO
Br J Haematol; 2019 May; 185(4):647-655. PubMed ID: 30864154
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cell transplantation for correction of primary immunodeficiencies.
Filipovich A
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S49-S52. PubMed ID: 18724301
[TBL] [Abstract][Full Text] [Related]
13. An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome.
Conley ME; Saragoussi D; Notarangelo L; Etzioni A; Casanova JL; ;
Clin Immunol; 2003 Dec; 109(3):272-7. PubMed ID: 14697741
[TBL] [Abstract][Full Text] [Related]
14. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.
Dupuis-Girod S; Medioni J; Haddad E; Quartier P; Cavazzana-Calvo M; Le Deist F; de Saint Basile G; Delaunay J; Schwarz K; Casanova JL; Blanche S; Fischer A
Pediatrics; 2003 May; 111(5 Pt 1):e622-7. PubMed ID: 12728121
[TBL] [Abstract][Full Text] [Related]
16. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
[TBL] [Abstract][Full Text] [Related]
17. Correction of the murine Wiskott-Aldrich syndrome phenotype by hematopoietic stem cell transplantation.
Strom TS; Li X; Cunningham JM; Nienhuis AW
Blood; 2002 Jun; 99(12):4626-8. PubMed ID: 12036897
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
[TBL] [Abstract][Full Text] [Related]
19. Successful HLA haploidentical HSCT with post-transplant cyclophosphamide in Wiskott-Aldrich syndrome.
Kreetapirom P; Hongeng S; Manuyakorn W; Anurathapan U; Pakakasama S; Sirachainan N; Andersson BS
Bone Marrow Transplant; 2017 Jun; 52(6):913-914. PubMed ID: 28287640
[No Abstract] [Full Text] [Related]
20. Autoimmune thyroiditis following HLA-matched sibling hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome.
Knight T; Kotz K; Savaşan S
Pediatr Transplant; 2018 Aug; 22(5):e13222. PubMed ID: 29761856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
